Clinical outcomes following real-world computed tomography angiography-derived fractional flow reserve testing in chronic coronary syndrome patients with calcification.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
20 09 2021
Historique:
received: 08 01 2020
revised: 23 03 2020
accepted: 29 05 2020
pubmed: 15 8 2020
medline: 21 10 2021
entrez: 15 8 2020
Statut: ppublish

Résumé

This study sought to investigate outcomes following a normal CT-derived fractional flow reserve (FFRCT) result in patients with moderate stenosis and coronary artery calcification, and to describe the relationship between the extent of calcification, stenosis, and FFRCT. Data from 975 consecutive patients suspected of chronic coronary syndrome with stenosis (30-70%) determined by computed CT angiography and FFRCT to guide downstream management decisions were reviewed. Median (range) follow-up time was 2.2 (0.5-4.2) years. Coronary artery calcium (CAC) scores were ≥400 in 25%, stenosis ≥50% in 83%, and FFRCT >0.80 in 51% of the patients. There was a lower incidence of the composite endpoint (death, myocardial infarction, hospitalization for unstable angina, and unplanned coronary revascularization) at 4.2 years in patients with any CAC and FFRCT > 0.80 vs. FFRCT ≤ 0.80 (3.9% and 8.7%, P = 0.04), however, in patients with CAC scores ≥400 the risk difference between groups did not reach statistical significance, 4.2% vs. 9.7% (P = 0.24). A negative relationship between CAC scores and FFRCT irrespective of stenosis severity was demonstrated. FFRCT shows promise in identifying patients with stenosis and calcification who can be managed without further downstream testing. Moreover, an inverse relationship between CAC levels and FFRCT was demonstrated. Studies are needed to further assess the clinical utility of FFRCT in patients with extensive coronary calcification.

Identifiants

pubmed: 32793947
pii: 5892436
doi: 10.1093/ehjci/jeaa173
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1182-1189

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Bjarne L Nørgaard (BL)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Martin B Mortensen (MB)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Erik Parner (E)

Department of Public Health, Section for Biostatistics, Aarhus University, Bartholins Alle 2, 8000 Aarhus C, Denmark.

Jonathon Leipsic (J)

Department of Radiology, St. Pauls Hospital, University of British Columbia, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.

Flemming H Steffensen (FH)

Department of Cardiology, Lillebaelt Hospital, Kabbaltoft 25, 7100 Vejle, Denmark.

Erik Lerkevang Grove (EL)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Ole N Mathiassen (ON)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Niels Peter Sand (NP)

Department of Cardiology, Hospital of Southwest Jutland, Finsensgade 35, 6700 Esbjerg, Denmark.

Kamilla Pedersen (K)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Katharina A Riedl (KA)

Department of Cardiology, University Heart and vascular Center, Martinistrase 52, 20246 Hamburg, Germany.

Morten Engholm (M)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Hans Erik Bøtker (HE)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Jesper M Jensen (JM)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensen Blv 99, 8200 Aarhus N, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH